Status | Study |
Terminated |
Study Name: South Miami Hospital Fibroid Registry Condition: Uterine Myomas, Leiomyomas, or Fibromas Date: 2015-01-20 |
Active, not recruiting |
Study Name: A Phase 2, Study to Evaluate the Safety and Efficacy Proellex® (Telapristone Acetate) Administered Vaginally in the Treatment of Uterine Fibroids Condition: Uterine Fibroids Date: 2014-12-18 Interventions: Drug: Placebo Comparator Safet |
Recruiting |
Study Name: Allogenic Mesenchymal Stem Cell for Bone Defect or Non Union Fracture Condition: Non Union Fracture Metaphyseal Fibrous Defect Date: 2014-10-07 Interventions: Biological: MSC subjects are implanted with allogenic mesenchymal stem cells from umbilical cord/ bone m |
Recruiting |
Study Name: Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall Reconstruction Condition: Hernia, Ventral Intestinal Fistula Fibromatosis, Abdominal Date: 2014-08-18 Interventions: Procedure: Abdominal wall reconstruction with Strattice |
Active, not recruiting |
Study Name: Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis Condition: Desmoid-Type Fibromatosis Date: 2014-02-17 Interventions: Other: Laboratory Biomarker Analysis |
Terminated |
Study Name: Observational Prospective Study on Patients With Symptomatic Uterine Fibroids Treated With VizAblate® Intrauterine-ultrasound Guided RF Ablation Condition: Menorrhagia Leiomyoma Uterine Fibroids Date: 2013-11-25 Interventions: Device: VizAblate System The VizAblate System is indicated for use in transcervical intrauterine-guided |
Active, not recruiting |
Study Name: Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis Condition: Desmoid Tumors Aggressive Fibromatosis Date: 2013-10-31 Interventions: Drug: PF-03084014 Treatment with the selective small-molecule >=-secretase inhibitor PF- 3084014 caus |
Recruiting |
Study Name: Peripheral Primitive Fibromatosis Condition: Peripheral Primitive Fibromatosis Date: 2013-02-25 Interventions: Other: MRI MRI every 3 months during the first year and then every 6 months during the second year and t |
Terminated |
Study Name: Long Term Outcomes Following Total Laparoscopic Hysterectomy and Laparoscopic Supracervical Hysterectomy Condition: Total Laparoscopic Hysterectomy Laparoscopic Supracervical Hysterectomy Date: 2011-02-02 Interventions: Procedure: TLH Total laparosco |
Recruiting |
Study Name: A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis Condition: Desmoid Tumor Date: 2010-12-06 Interventions: Drug: Sirolimus Loading do |